Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

LOGIN HERE

Cancel

BSE Code : 543960 | NSE Symbol : CONCORDBIO | ISIN : INE338H01029 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |

Profit and Loss

Particulars (₹ Cr)	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Revenue From Operations	1,016.94	853.17	712.93	616.94	512.33
Sale of Products	995.33	828.35	703.99	602.42	498.18
Sale of Services	2.73	2.28	4.45	1.64	0.00
Income from Investment and Financial Services	0.00	0.00	0.00	0.00	0.00
Income from Insurance Operations	0.00	0.00	0.00	0.00	0.00
Other Operating Revenue	18.88	22.54	4.49	12.89	14.15
Less: Excise Duty / GST	0.00	0.00	0.00	0.00	0.00
Revenue From Operations - Net	1,016.94	853.17	712.93	616.94	512.33
Other Income	33.78	35.31	23.42	13.81	31.37
Total Revenue	1,050.72	888.48	736.35	630.75	543.70
Changes in Inventories	-12.08	-15.63	-23.98	-39.05	-4.85
Cost of Material Consumed	184.54	167.07	157.26	131.17	124.01
Internally Manufactured Intermediates Consumed	0.00	0.00	0.00	0.00	0.00
Purchases of Stock-in-Trade	56.74	28.77	30.73	19.45	10.78
Employee Benefits	123.05	110.28	95.69	69.47	62.24
Total Other Expenses	233.14	219.39	179.95	108.36	116.08
Manufacturing / Operating Expenses	132.97	122.59	88.74	52.85	67.70
Administrative and Selling Expenses	91.08	82.93	67.90	44.87	32.27
Other Expenses	9.09	13.88	23.31	10.64	16.12
Finance Costs	2.55	4.51	5.48	0.67	0.70
Depreciation and Amortization	53.59	54.03	50.05	27.52	21.25
Total Expenses	641.53	568.42	495.19	317.58	330.21
Profit Before Exceptional Items and Tax	409.19	320.05	241.16	313.17	213.49
Exceptional Items Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Extraordinary Items and Tax	409.19	320.05	241.16	313.17	213.49
Extraordinary Items Before Tax	0.00	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	409.19	320.05	241.16	313.17	213.49
Taxation	104.46	81.93	62.59	77.83	44.53
Current Tax	99.83	79.53	58.49	75.72	54.47
MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	4.63	2.38	3.71	2.34	-10.00
Other Tax	0.00	0.00	0.00	0.00	0.00
Adjust for Previous Year	0.00	0.02	0.39	-0.23	0.06
Profit After Tax	304.73	238.13	178.57	235.33	168.96
Extraordinary Items After Tax	0.00	0.00	0.00	0.00	0.00
Discontinued Operations After Tax	0.00	0.00	0.00	0.00	0.00
Profit / (Loss) from Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Tax Expenses of Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Shareholders	304.73	238.13	178.57	235.33	168.96
Adjustments to Net Income	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Equity Shareholders	304.73	238.13	178.57	235.33	168.96
Earning Per Share - Basic	29.13	22.76	17.07	22.50	177.66
Earning Per Share - Diluted	29.13	22.76	17.07	22.50	177.66

LOGIN HERE

LOGIN HERE

Concord Biotech Ltd

Profit and Loss